Vor Biopharma Inc.
NASDAQ:VOR
0.2238 (USD) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 12.226 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.9 | 0.943 | 0.892 | 2.089 | 1.234 | 2.79 | 3.059 | 2.388 | 0.575 | 0.426 | 1.152 | 1.13 | 0.354 | 0.633 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | -0.9 | -0.943 | 11.334 | -2.089 | -1.234 | -2.79 | -3.059 | -2.388 | -0.575 | -0.426 | -1.152 | -1.13 | -0.354 | -0.633 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0.927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 26.701 | 25.348 | 21.817 | 21.823 | 24.322 | 20.897 | 27.606 | 23.897 | 21.915 | 17.062 | 16.875 | 15.333 | 15.28 | 12.693 | 12.925 | 12.97 | 8.941 | 11.33 | 8.142 | 5.975 | 6.171 | 2.964 | 1.568 | 0.834 | 0.834 |
| General & Administrative Expenses
| 6.59 | 5.963 | 6.696 | 7.212 | 8.004 | 7.227 | 7.71 | 8.277 | 8.507 | 7.663 | 7.226 | 6.459 | 7.52 | 5.613 | 5.677 | 5.41 | 4.789 | 4.333 | 3.643 | 2.065 | 1.707 | 0.964 | 2.148 | 0.553 | 0.553 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.9 | -0.943 | -0.892 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.59 | 5.963 | 6.696 | 6.312 | 7.061 | 6.335 | 7.71 | 8.277 | 8.507 | 7.663 | 7.226 | 6.459 | 7.52 | 5.613 | 5.677 | 5.41 | 4.789 | 4.333 | 3.643 | 2.065 | 1.707 | 0.964 | 2.148 | 0.553 | 0.553 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 33.291 | 31.311 | 28.513 | 28.135 | 31.383 | 27.232 | 35.316 | 32.174 | 30.422 | 24.725 | 24.101 | 21.792 | 22.8 | 18.306 | 18.602 | 18.38 | 13.73 | 15.663 | 11.785 | 8.04 | 7.878 | 3.928 | 3.716 | 1.371 | 1.371 |
| Operating Income
| -33.291 | -31.311 | -28.513 | -29.035 | -32.326 | -28.124 | -35.316 | -32.174 | -30.422 | -24.725 | -24.101 | -21.792 | -22.8 | -18.306 | -18.602 | -18.38 | -13.73 | -15.663 | -11.785 | -8.04 | -7.878 | -3.928 | -3.716 | -1.387 | -1.387 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.805 | 0.599 | 0.954 | 1.196 | 1.522 | 1.863 | 2.126 | 2.195 | 1.989 | 0.815 | 0.313 | 0.133 | 0.063 | 0.054 | 0.048 | 0.01 | 0.007 | 0 | 0 | 0 | 0.029 | 0.035 | 0.077 | -0.267 | -0.267 |
| Income Before Tax
| -32.486 | -30.712 | -27.559 | -27.839 | -30.804 | -26.261 | -33.19 | -29.979 | -28.433 | -23.91 | -23.788 | -21.659 | -22.737 | -18.252 | -18.554 | -18.37 | -13.723 | -15.663 | -11.785 | -8.04 | -7.849 | -3.893 | -3.639 | -1.654 | -1.654 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -2.148 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.9 | 0 | 0 | 0.9 | 0.565 | 1.424 | 3.065 | -1.989 | -1.011 | -0.313 | -0.133 | -0.063 | 68.899 | -0.756 | 0 | -0.322 | 43.337 | 0 | 0 | 0 | 0.035 | 0.507 | 0.38 | 0.38 |
| Net Income
| -32.486 | -30.712 | -27.559 | -27.839 | -30.804 | -26.261 | -33.19 | -29.979 | -26.444 | -22.899 | -23.475 | -21.526 | -22.674 | -18.252 | -18.554 | -18.37 | -13.723 | -15.663 | -11.785 | -8.04 | -7.849 | -3.893 | -4.146 | -2.034 | -2.034 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.148 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.26 | -0.45 | -0.4 | -0.41 | -0.45 | -0.39 | -0.49 | -0.45 | -0.4 | -0.49 | -0.62 | -0.57 | -0.61 | -0.49 | -0.5 | -0.5 | -0.62 | -0.7 | -0.97 | -0.66 | -0.64 | -0.32 | -35.74 | -18.16 | -18.16 |
| EPS Diluted
| -0.26 | -0.45 | -0.4 | -0.41 | -0.45 | -0.39 | -0.49 | -0.45 | -0.4 | -0.49 | -0.62 | -0.57 | -0.61 | -0.49 | -0.5 | -0.5 | -0.62 | -0.7 | -0.97 | -0.66 | -0.64 | -0.32 | -35.63 | -18.06 | -18.06 |
| EBITDA
| -33.291 | -30.446 | -27.662 | -29.035 | -31.383 | -27.232 | -34.423 | -31.304 | -29.585 | -24.093 | -23.209 | -21.217 | -22.374 | -17.911 | -18.228 | -18.026 | -13.419 | -15.421 | -11.593 | -7.935 | -7.812 | -3.852 | -3.684 | -1.378 | -1.378 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -2.227 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |